| Name / ID | Type | Disease | RRID | Causal gene(s) | Mutation | Originating lab |
|---|---|---|---|---|---|---|
| CENSOi071-A | Cell Lines | SCA3 | CVCL_E4G3 |
ATXN3 | 75/14 CAG | Censo and Axol Bioscience Company (CENSO) |
| ChHES-472 | Cell Lines | SCA3 | CVCL_XA13 |
ATXN3 | 74 CAG | National Engineering and Research Center of Human Stem Cell |
| CHOPi002-A | Cell Lines | SCA2 | CVCL_UL69 |
ATXN2 | 23/33 CAG | The Children's Hospital of Philadelphia (CHOP) |
| CHOPi003-A | Cell Lines | SCA2 | CVCL_UL70 |
ATXN2 | 23/43 CAG | The Children's Hospital of Philadelphia (CHOP) |
| CHUQi002-A | Cell Lines | SACS/ARSACS/SPAX6 | CVCL_E3RD |
SACS | 0c.9497-9498delTT | CRCHU de Quebec's induced pluripotency stem cells production platform |
| CHUQi003-A | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | — | CHU de Quebec-Universite Laval Research Center (CHUQ) |
| CHUQi004-A | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | 0c.6594delT/c.7504C>T | CRCHU de Quebec's induced pluripotency stem cells production platform |
| CHUQi005-A | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | 0c.4205A>T/c.5836 T>C | CRCHU de Quebec's induced pluripotency stem cells production platform |
| CHUQi006-A | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | 0c.6594delT | CRCHU de Quebec's induced pluripotency stem cells production platform |
| CHUQi007-A | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | 0c.6594delT | CRCHU de Quebec's induced pluripotency stem cells production platform |
| CHUQi008-A | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | 0c.6594delT | CRCHU de Quebec's induced pluripotency stem cells production platform |
| CHUQi009-A | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | 0c.6594delT | CRCHU de Quebec's induced pluripotency stem cells production platform |
| CHUQi010-A | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | 0c.6594delT | CRCHU de Quebec's induced pluripotency stem cells production platform |
| CJUHi001 | Cell Lines | SCA1 | CVCL_C6TW |
ATXN1 | ?/44 CAG | China-Japan Union Hospital of Jilin University (CJUH) |
| CNP-SNCAGFP Tg mice | Mouse Models | MSA/OPCA | — |
Sporadic | expressing human αsyn-green fluorescent protein (GFP) fusion proteins in oligodendrocytes | Kyoto University |
| CNP-α-syn transgenic mouse | Mouse Models | MSA/OPCA | — |
Sporadic | Expression of wild-type human α-syn and P301L mutant tau (tauP301L) | University of Pennsylvania School of Medicine |
| conditional Ttbk2 KO (Ttbk2c.mut) | Mouse Models | SCA11 | — |
TTBK2 | Ubiquitous conditional Ttbk2 knockout | Duke University |
| conditional Ttbk2 KO (Ttbk2pcp2) | Mouse Models | SCA11 | — |
TTBK2 | Conditional Ttbk2 knockout specifically in the Purkinje cells | Duke University |
| conditional Ttbk2 KO (Ttbk2slc1a3) | Mouse Models | SCA11 | — |
TTBK2 | Conditional Ttbk2 knockout specifically in the Bergmann glia | Duke University |
| Corrected iPSC (C-iPSC) | Cell Lines | SCA3 | — |
ATXN3 | 26/- CAG (ΔpolyQ) | Third affiliated Hospital of Guangzhou Medical University |
| Cre-loxP inducible α-synuclein | Mouse Models | MSA/OPCA | — |
Sporadic | Expression of inducible α-synuclein regulated by Cre-loxP | Hirosaki University Graduate School of Medicine |
| CRICKi-12-A | Cell Lines | MSA/OPCA, PD | CVCL_C5T4 |
SNCA | c.G152A mutation in exon 3 of SNCA | The Francis Crick Institute |
| CRICKi011-A | Cell Lines | MSA/OPCA, PD | CVCL_C5T3 |
SNCA | c.G152A mutation in exon 3 of SNCA | The Francis Crick Institute |
| CS25i-18n2 / SN-2 | Cell Lines | SCA12 | — |
PPP2R2B | 10/14 CAG; parental line of SN-2C (isogenic pair) | Johns Hopkins University SN-2 derived from iPSC Core in Cedars-Sinai (Los Angeles, CA) |
| CSC-30B, C, D (MSA-C) | Cell Lines | MSA/OPCA | — |
? | — | Lund University |
| CSC-4B (MSA-C) | Cell Lines | MSA/OPCA | — |
? | — | Lund University |
| CSC-6A (MSA-P) | Cell Lines | MSA/OPCA | — |
? | — | Lund University |
| CSC34D, F, M (MSA-P) | Cell Lines | MSA/OPCA | — |
? | — | Lund University |
| CSUXHi001-A/XHCSUi001-A | Cell Lines | SCA3 | CVCL_XI42 |
ATXN3 | ?/74 CAG | Xiangya Hospital of Central South University |
| CSUXHi002-A | Cell Lines | SCA1 | CVCL_ZA46 |
ATXN1 | ?/65 CAG | Xiangya Hospital of Central South University |
| CSUXHi005-A | Cell Lines | SCA3 | CVCL_A4GP |
ATXN3 | ?/76 CAG | Xiangya Hospital of Central South University |
| CU19008 | Cell Lines | SPG7 | — |
SPG7 | c.1715C>T | University of Milan |
| Dab1 null mice | Mouse Models | SCA37 | — |
DAB1 | Dab1 knock-out | Fred Hutchinson Cancer Research Center |
| Dab1 scrambler (scm) mice | Mouse Models | SCA37 | IMSR_JAX:002043 |
DAB1 | Spontaneous autosomal recessive mutation in Dab1 | The Jackson Laboratory |
| EAOH1 | Cell Lines | AOA1 | — |
APTX | 689insT (homozygous) | Nara Medical University |
| EAOH2 | Cell Lines | AOA1 | — |
APTX | 689insT (homozygous) | Nara Medical University |
| Elovl4 heterozygous KO mice (no ataxia tested) | Mouse Models | SCA34 | — |
ELOVL4 | Heterozygous knockout of Elovl4 | National Institutes of Health |
| Elovl4 homozygous KO mice (perinatal lethal) | Mouse Models | SCA34 | — |
ELOVL4 | Homozygous knockout of Elovl4 | National Institutes of Health |
| Elovl5-/- mice | Mouse Models | SCA38 | — |
ELOVL5 | Homozygous Elovl5 knock-out mice | University of Texas Southwestern Medical Center at Dallas |
| Emx1-Cre+/−; Kcna1del/− | Mouse Models | EA1 | — |
KCNA1 | Corticolimbic heterozygous Kcna1 conditional knockout mice | Southern Methodist University |
| ESi063-A | Cell Lines | SACS/ARSACS/SPAX6 | CVCL_VP83 |
SACS | c.9938delC(p.G3313Qfs*11)/c.11374C>T(p.R3792*) | Research Center Principe Felipe |
| ESi064-A | Cell Lines | SACS/ARSACS/SPAX6 | CVCL_UG20 |
SACS | c.11374C > T (p.R3792X) | Research Center Principe Felipe |
| eSpg7 KO | Mouse Models | SPG7 | — |
SPG7 | Spg7 and Afg3l1 full body knockout | University of Cologne |
| F664S (p1) | Cell Lines | SCA28 | — |
AFG3L2 | p.F664S (p1) | IRCCS Ospedale San Raffaele |
| F664S (p2) | Cell Lines | SCA28 | — |
AFG3L2 | p.F664S (p2) | IRCCS Ospedale San Raffaele |
| fAP1 | Cell Lines | AOA1 | — |
APTX | pW279X/pW279X; sibling of fAP2 | — |
| fAP2 | Cell Lines | AOA1 | — |
APTX | pW279X/pW279X; sibling of fAP1 | — |
| fAP4 | Cell Lines | AOA1 | — |
APTX | pW279X/pW279X | — |
| FARSF56-7 | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | c.8844delT (homozygous) | Obtained from: CRCHU de Quebec's induced pluripotency stem cells production platform |
| FARSM50-5 | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | c.8844delT (homozygous) | Obtained from: CRCHU de Quebec's induced pluripotency stem cells production platform |
Twenty Twenty-Five
Designed with WordPress
